Fusion Antibodies raises £3m for Covid-19 research
(Sharecast News) - Fusion Antibodies has raised £3m from investors to extend its research to cover potential treatments for Covid-19.
Read moreWed, 29th Jan 2020 09:32
(Sharecast News) - Fusion Antibodies has raised £3m from investors to extend its research to cover potential treatments for Covid-19.
Read moreFusion Antibodies Trading In Line With Expectations Amid Outbreak
Read moreDIRECTOR DEALINGS SUMMARY: IWG And Man Chiefs Buy GBP3 Million Worth
Read moreDIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Boss Buys GBP200,000 Worth
Read moreFusion Antibodies Expects Annual Revenue Rise Ahead Of Expectations
Read moreDIRECTOR DEALINGS: Fusion Antibodies Non-Executive Mawson Buys Shares
Read moreDIRECTOR DEALINGS: Fusion Antibodies Non-Exec Mawson Buys Shares
Read more(Sharecast News) - Fusion Antibodies on Monday reported a narrowed loss after revenue more than doubled following the launch of its RAMP service.
Read moreFusion Antibodies Revenue Takes Off But Order Visibility Cloudy
Read more(Sharecast News) - Preclinical antibody discovery company Fusion Antibodies updated the market on the six months ended 30 September on Tuesday, reporting continued revenue growth amid the commercial roll out of new services.
Read moreFusion Antibodies Predicts Rise In Interim Revenue And Orders
Read more(Alliance News) - Fusion Antibodies PLC said Wednesday that its Chief Executive Officer and two Non-Executive Directors have bought around GBP31,794 in shares in the company in deals on Executive
Read more(Alliance News) - Fusion Antibodies PLC on Tuesday said its loss gapped wider after a weak first half brought annual revenue down 19%, though this was followed by a much stronger second antibody a
Read moreLONDON (Alliance News) - Fusion Antibodies PLC on Wednesday reported an improved performance in the second half of its recently ended financial year after "disappointing" first company a
Read more